1-(4-Methoxyphenyl)piperazine Dihydrochloride

We are 1-(4-Methoxyphenyl)piperazine Dihydrochloride CAS:38869-47-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 1-(4-Methoxyphenyl)piperazine Dihydrochloride
CAS.NO:38869-47-5
Synonyms:
1-(4-methoxyphenyl)piperazine,dihydrochloride
1-(4-Methoxyphenyl)piperazine dihydrochloride
4-(1-Piperazinyl)anisole Dihydrochloride

Molecular Formula: C11H18Cl2N2O
Molecular Weight:265.17900

Physical and Chemical Properties:
Density: /
Boiling point:344ºC at 760 mmHg
Melting point: 240 °C (dec.)(lit.)
Flash point: 161.8ºC
Refractive index: /

Specification:
Appearance: White powder
Purity:≥98%
Moisture Content: ≤1.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Ketoconazole CAS:65277-42-1

Related News: Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it.463-71-8 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.5-bromo-3- (trifluorometil) -2-piridinacarbonitrilo CAS:1214377-57-7 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.6-chloro-1-hydroxybenzotriazole CAS:26198-19-6 Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”